UTMD
Utah Medical Products Inc
74.10$
-0.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 77.6% | 78.5% | 79.1% | 78.7% | 78.4% | 78.6% | 78.7% | 78.1% | 79.1% | 79.8% | 80.7% | 80.8% | |
| -0.2% | 68.6% | 69.3% | 68.6% | 68.2% | 67.7% | 68.0% | 68.0% | 69.1% | 70.0% | 70.3% | 70.3% | |
| 67.2% | 68.6% | 69.3% | 68.6% | 68.2% | 67.7% | 68.0% | 68.0% | 69.1% | 70.0% | 70.3% | 70.3% | |
| 2.7% | 2.5% | 2.7% | 2.8% | 2.9% | 3.3% | 3.2% | 3.0% | 3.1% | 2.9% | 2.9% | 2.9% | |
| 7.4% | 7.1% | 6.8% | 7.0% | 7.0% | 7.2% | 7.1% | 6.8% | 6.7% | 6.5% | 7.0% | 7.2% | |
| 10.2% | 10.1% | 10.1% | 10.5% | 10.8% | 11.1% | 11.2% | 11.7% | 11.5% | 11.5% | 11.2% | 11.2% | |
| 4.3% | 3.7% | 3.2% | 3.0% | 2.8% | 2.3% | 2.0% | 1.6% | 1.1% | 0.7% | 0.3% | 0.3% | |
| 5.7% | 5.3% | 5.7% | 4.6% | 4.2% | 4.2% | 4.5% | 2.7% | 3.1% | 2.7% | 3.2% | 2.0% | |
| 3.2% | 3.5% | 4.0% | 3.0% | 2.6% | 3.1% | 3.5% | 1.9% | 2.5% | 2.1% | 2.8% | 1.7% | |
| – | 0.0% | – | – | – | 0.0% | – | – | – | – | – | – | |
| 0.4% | 0.6% | 0.7% | 0.6% | 0.8% | 0.6% | 0.7% | 0.6% | 0.6% | 0.7% | 1.0% | 0.7% | |
| 94.3% | 94.7% | 94.3% | 95.4% | 95.8% | 95.8% | 95.5% | 97.3% | 96.9% | 97.3% | 96.8% | 98.0% | |
| 103.0% | 102.1% | 102.6% | 104.1% | 103.4% | 105.5% | 104.6% | 105.0% | 104.9% | 105.0% | 104.7% | 105.9% | |
| 2.8% | 2.7% | 2.7% | 2.7% | 2.7% | 2.8% | 2.7% | 2.7% | 2.6% | 2.6% | 2.6% | 2.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.